Literature DB >> 12969230

Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis.

Ji J Lim1, Sungmin Kang, Mi R Lee, Hyun K Pai, Hye J Yoon, Jae I Lee, Sam P Hong, Chang Y Lim.   

Abstract

BACKGROUND: Vascular endothelial growth factor (VEGF) has been demonstrated to play an important role in tumor angiogenesis and to influence prognosis in many cancers. But, its significance in salivary gland carcinomas has not been elucidated. The authors investigated the association between VEGF expression and clinicopathological factors, p53, and Ki-67 to verify its validity as a prognostic factor.
METHODS: Surgical specimens from 45 patients with salivary gland carcinoma were examined for VEGF, p53, and Ki-67 expression by immunohistochemical staining. The results were compared with the clinicopathological factors and the relationships were correlated.
RESULTS: VEGF expression was low in 14 cases, moderate in 15 cases, and high in 16 cases. It was significantly correlated with a variety of clinicopathological factors such as TNM stage, perineural and vascular invasion, and recurrence. VEGF showed significant association with the expression of p53 but not with that of Ki-67. Univariate analysis showed that age, gender, lymph node metastasis, vascular invasion, p53, Ki-67, and VEGF expression correlate with prognosis. Multivariate analysis demonstrated that VEGF is an independent prognostic factor for patients with salivary gland carcinomas.
CONCLUSIONS: The results of this study suggest that VEGF expression is correlated with p53 expression and that it may have prognostic value in salivary gland carcinomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969230

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  19 in total

1.  Parotid carcinoma: Current diagnostic workup and treatment.

Authors:  Vincent L M Vander Poorten; Francis Marchal; Sandra Nuyts; Paul M J Clement
Journal:  Indian J Surg Oncol       Date:  2010-11-21

2.  Characteristics of benign lymphoadenosis of oral mucosa.

Authors:  Shu-Xia Li; Shi-Feng Yu; Kai-Hua Sun
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

3.  Neither expression of VEGF-C/D nor lymph vessel density supports lymphatic invasion as the mechanism responsible for local spread of recurrent salivary pleomorphic adenoma.

Authors:  R Salzman; I Stárek; L Kučerová; A Skálová; J Hoza
Journal:  Virchows Arch       Date:  2014-01       Impact factor: 4.064

4.  Differential expression of c-kit and CD43 in histological subtypes of adenoid cystic carcinoma of salivary gland.

Authors:  Mohamed M Ahmed; Eman A Abo-Hager
Journal:  Saudi Dent J       Date:  2010-01-04

5.  Prognostic significance of VEGF immunohistochemical expression in oral cancer: a meta-analysis of the literature.

Authors:  Su-Feng Zhao; Xu-Dong Yang; Ming-Xing Lu; Guo-Wen Sun; Yu-Xin Wang; Yin-Kai Zhang; Yu-Mei Pu; En-Yi Tang
Journal:  Tumour Biol       Date:  2013-06-05

Review 6.  New agents in the treatment for malignancies of the salivary and thyroid glands.

Authors:  Ranee Mehra; Roger B Cohen
Journal:  Hematol Oncol Clin North Am       Date:  2008-12       Impact factor: 3.722

7.  Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland.

Authors:  Junya Ono; Yasuo Okada
Journal:  Odontology       Date:  2017-12-14       Impact factor: 2.634

8.  Relationship between VEGF and p53 expression and tumor cell proliferation in human gastrointestinal carcinomas.

Authors:  Elvira Montero; Carmen Abreu; Paola Tonino
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-17       Impact factor: 4.553

9.  Prognostic value of expression of molecular markers in adenoid cystic cancer of the salivary glands compared with lymph node metastasis: a retrospective study.

Authors:  Seok Ki Lee; Min Su Kwon; Yoon Se Lee; Seung-Ho Choi; Sang Yoon Kim; Kyoung Ja Cho; Soon Yuhl Nam
Journal:  World J Surg Oncol       Date:  2012-12-11       Impact factor: 2.754

Review 10.  Activity of chemotherapy in the palliative treatment of salivary gland tumors: review of the literature.

Authors:  Sophia Rizk; Annie Robert; Annick Vandenhooft; Mario Airoldi; Gabriela Kornek; Jean-Pascal Machiels
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-04-06       Impact factor: 3.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.